002286.SZ
保龄宝
SZSE · Healthcare · C 制造业 · CN
CNY 7.77
−1.40%Year over year
Reported trailing growth
- Revenue
- +11.0%
- EBITDA
- —
- EBIT
- -0.5%
- EPS
- +8.4%
- Free cash flow
- +99.4%
- Operating cash flow
- +5.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +0.5%
- EBITDA
- +5.1%
- EBIT
- +3.7%
- Net income
- +4.2%
- EPS
- +4.4%
- Free cash flow
- -26.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026